Keeping Track Of IDMP Moves In The EU, US And Beyond
This article was originally published in SRA
Executive Summary
Ian Schofield reports on how regulatory agencies are faring with regard to adopting five ISO standards for the identification of medicinal products.
You may also be interested in...
New EU Action Plan To Boost Innovation By Smaller Firms
A new action plan from the European Medicines Agency is intended to promote innovation in SMEs by raising awareness of the regulatory tools and support available from the agency, offering more training and education, and promoting collaboration among SMEs, academia, and other stakeholders.
'Don't Compromise The Pharma Innovation System,' Says Outgoing IFPMA Head Thomas Cueni
Thomas Cueni is stepping down after seven years at the helm of the International Federation of Pharmaceutical Manufacturers and Associations. In an interview with the Pink Sheet ahead of his retirement, he reflects on the proposed pandemic treaty, what still needs to be done to ensure equitable access to medicines, the importance of tackling AMR, moves towards regulatory reliance – and what his post-IFPMA life might look like.
EU Warns Of Life-Threatening Interactions Between Paxlovid & Some Immunosuppressants
The EU’s pharmacovigilance committee says that a review of the available evidence showed that in several cases, blood levels of immunosuppressants increased rapidly to toxic levels in patients who were taking the Pfizer drug.